Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
7.78
-0.23 (-2.87%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $496.42 million as of October 29, 2024. Its market cap has increased by 272.40% in one year.
Market Cap
496.42M
Enterprise Value
275.95M
1-Year Change
272.40%
Ranking
Category
Stock Price
$7.78
Market Cap Chart
Since June 19, 2014, Larimar Therapeutics's market cap has increased from $410.90M to $496.42M, an increase of 20.81%. That is a compound annual growth rate of 1.84%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 29, 2024 | 496.40M | 148.45% |
Dec 29, 2023 | 199.80M | 11.81% |
Dec 30, 2022 | 178.70M | -6.49% |
Dec 31, 2021 | 191.10M | -41.88% |
Dec 31, 2020 | 328.80M | 692.29% |
Dec 31, 2019 | 41.50M | -77.26% |
Dec 31, 2018 | 182.50M | 43.70% |
Dec 29, 2017 | 127.00M | 46.14% |
Dec 30, 2016 | 86.90M | -49.27% |
Dec 31, 2015 | 171.30M | -75.54% |
Dec 31, 2014 | 700.30M | 70.43% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Emergent BioSolutions | 522.37M |
Sage Therapeutics | 521.37M |
Auna S.A. | 514.47M |
UroGen Pharma | 511.69M |
SI-BONE | 511.59M |
Canopy Growth | 505.84M |
Verve Therapeutics | 502.67M |
Pacific Biosciences of California | 501.45M |